nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—NAT1—prostate cancer	0.348	0.729	CbGaD
Sulfamethoxazole—NAT2—prostate cancer	0.11	0.229	CbGaD
Sulfamethoxazole—ALB—Abiraterone—prostate cancer	0.0253	0.0844	CbGbCtD
Sulfamethoxazole—CYP2C8—Nilutamide—prostate cancer	0.0236	0.0787	CbGbCtD
Sulfamethoxazole—CYP3A4—prostate cancer	0.0199	0.0415	CbGaD
Sulfamethoxazole—CYP2C8—Abiraterone—prostate cancer	0.0195	0.0652	CbGbCtD
Sulfamethoxazole—ALB—Estrone—prostate cancer	0.0183	0.061	CbGbCtD
Sulfamethoxazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0182	0.0607	CbGbCtD
Sulfamethoxazole—CYP2C9—Nilutamide—prostate cancer	0.0164	0.0549	CbGbCtD
Sulfamethoxazole—CYP2C9—Bicalutamide—prostate cancer	0.0164	0.0549	CbGbCtD
Sulfamethoxazole—CYP2C8—Cabazitaxel—prostate cancer	0.0144	0.0482	CbGbCtD
Sulfamethoxazole—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0126	0.042	CbGbCtD
Sulfamethoxazole—ALB—Estradiol—prostate cancer	0.0105	0.035	CbGbCtD
Sulfamethoxazole—NAT2—urine—prostate cancer	0.01	0.307	CbGeAlD
Sulfamethoxazole—CYP2C9—Estrone—prostate cancer	0.00984	0.0329	CbGbCtD
Sulfamethoxazole—CYP3A4—Bicalutamide—prostate cancer	0.00955	0.0319	CbGbCtD
Sulfamethoxazole—PTGS1—Etoposide—prostate cancer	0.00917	0.0306	CbGbCtD
Sulfamethoxazole—ALB—Prednisone—prostate cancer	0.00902	0.0301	CbGbCtD
Sulfamethoxazole—CYP3A4—Estramustine—prostate cancer	0.00888	0.0297	CbGbCtD
Sulfamethoxazole—CYP2C8—Estradiol—prostate cancer	0.0081	0.0271	CbGbCtD
Sulfamethoxazole—CYP3A4—Flutamide—prostate cancer	0.00792	0.0264	CbGbCtD
Sulfamethoxazole—CYP3A4—Abiraterone—prostate cancer	0.00792	0.0264	CbGbCtD
Sulfamethoxazole—CYP2C9—Capecitabine—prostate cancer	0.00746	0.0249	CbGbCtD
Sulfamethoxazole—CYP3A4—Cabazitaxel—prostate cancer	0.00585	0.0196	CbGbCtD
Sulfamethoxazole—CYP3A4—Estrone—prostate cancer	0.00572	0.0191	CbGbCtD
Sulfamethoxazole—CYP2C9—Estradiol—prostate cancer	0.00565	0.0189	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—prostate cancer	0.00529	0.0177	CbGbCtD
Sulfamethoxazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0051	0.017	CbGbCtD
Sulfamethoxazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00374	0.0125	CbGbCtD
Sulfamethoxazole—CYP3A4—Mitoxantrone—prostate cancer	0.0034	0.0114	CbGbCtD
Sulfamethoxazole—CYP3A4—Estradiol—prostate cancer	0.00329	0.011	CbGbCtD
Sulfamethoxazole—NAT1—prostate gland—prostate cancer	0.00327	0.1	CbGeAlD
Sulfamethoxazole—CYP3A4—Prednisone—prostate cancer	0.00283	0.00944	CbGbCtD
Sulfamethoxazole—NAT1—seminal vesicle—prostate cancer	0.00276	0.0847	CbGeAlD
Sulfamethoxazole—NAT2—renal system—prostate cancer	0.00245	0.075	CbGeAlD
Sulfamethoxazole—NAT1—urethra—prostate cancer	0.00219	0.067	CbGeAlD
Sulfamethoxazole—CYP3A4—Etoposide—prostate cancer	0.00215	0.00717	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—prostate cancer	0.00196	0.00656	CbGbCtD
Sulfamethoxazole—NAT1—bone marrow—prostate cancer	0.00168	0.0516	CbGeAlD
Sulfamethoxazole—CYP2C9—urine—prostate cancer	0.00156	0.0477	CbGeAlD
Sulfamethoxazole—CYP3A4—Doxorubicin—prostate cancer	0.00146	0.00489	CbGbCtD
Sulfamethoxazole—NAT1—testis—prostate cancer	0.00144	0.0441	CbGeAlD
Sulfamethoxazole—UGT1A9—renal system—prostate cancer	0.00132	0.0405	CbGeAlD
Sulfamethoxazole—CYP3A4—urine—prostate cancer	0.00119	0.0364	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—prostate cancer	0.00104	0.032	CbGeAlD
Sulfamethoxazole—PTGS1—prostate gland—prostate cancer	0.00051	0.0156	CbGeAlD
Sulfamethoxazole—PTGS1—seminal vesicle—prostate cancer	0.000431	0.0132	CbGeAlD
Sulfamethoxazole—CYP2C8—renal system—prostate cancer	0.000429	0.0131	CbGeAlD
Sulfamethoxazole—ALB—testis—prostate cancer	0.000394	0.0121	CbGeAlD
Sulfamethoxazole—PTGS1—epithelium—prostate cancer	0.000375	0.0115	CbGeAlD
Sulfamethoxazole—PTGS1—renal system—prostate cancer	0.000348	0.0107	CbGeAlD
Sulfamethoxazole—CYP3A4—renal system—prostate cancer	0.00029	0.0089	CbGeAlD
Sulfamethoxazole—ALB—lymph node—prostate cancer	0.000286	0.00876	CbGeAlD
Sulfamethoxazole—Sulfathiazole—CYP19A1—prostate cancer	0.000282	0.169	CrCbGaD
Sulfamethoxazole—CYP2C8—testis—prostate cancer	0.000277	0.00849	CbGeAlD
Sulfamethoxazole—Dapsone—NAT2—prostate cancer	0.000244	0.146	CrCbGaD
Sulfamethoxazole—PTGS1—testis—prostate cancer	0.000225	0.00689	CbGeAlD
Sulfamethoxazole—PTGS1—lymph node—prostate cancer	0.000163	0.00499	CbGeAlD
Sulfamethoxazole—Dapsone—CYP2C18—prostate cancer	0.000155	0.0928	CrCbGaD
Sulfamethoxazole—Sulfaphenazole—CYP2A6—prostate cancer	0.000149	0.0893	CrCbGaD
Sulfamethoxazole—Sulfadiazine—CYP2E1—prostate cancer	0.000116	0.0693	CrCbGaD
Sulfamethoxazole—Dapsone—MPO—prostate cancer	0.000115	0.0691	CrCbGaD
Sulfamethoxazole—Dapsone—CYP3A5—prostate cancer	0.000102	0.0611	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2E1—prostate cancer	7.85e-05	0.0471	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CYP2C19—prostate cancer	7.77e-05	0.0466	CrCbGaD
Sulfamethoxazole—Sulfadiazine—CYP3A4—prostate cancer	7.28e-05	0.0437	CrCbGaD
Sulfamethoxazole—Dapsone—CYP2E1—prostate cancer	7e-05	0.042	CrCbGaD
Sulfamethoxazole—Dapsone—CYP2C19—prostate cancer	6.94e-05	0.0416	CrCbGaD
Sulfamethoxazole—Eye disorder—Prednisone—prostate cancer	5.06e-05	0.000556	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Epirubicin—prostate cancer	5.02e-05	0.000552	CcSEcCtD
Sulfamethoxazole—Asthenia—Estradiol—prostate cancer	4.96e-05	0.000546	CcSEcCtD
Sulfamethoxazole—Sulfanilamide—CYP3A4—prostate cancer	4.94e-05	0.0297	CrCbGaD
Sulfamethoxazole—Neutropenia—Epirubicin—prostate cancer	4.94e-05	0.000544	CcSEcCtD
Sulfamethoxazole—Pruritus—Estradiol—prostate cancer	4.9e-05	0.000539	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—prostate cancer	4.89e-05	0.000538	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Prednisone—prostate cancer	4.89e-05	0.000538	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—prostate cancer	4.84e-05	0.000533	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Epirubicin—prostate cancer	4.83e-05	0.000531	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—prostate cancer	4.8e-05	0.000528	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—prostate cancer	4.78e-05	0.000526	CcSEcCtD
Sulfamethoxazole—Cough—Docetaxel—prostate cancer	4.77e-05	0.000524	CcSEcCtD
Sulfamethoxazole—Vertigo—Capecitabine—prostate cancer	4.75e-05	0.000523	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Mitoxantrone—prostate cancer	4.75e-05	0.000523	CcSEcCtD
Sulfamethoxazole—Pneumonia—Epirubicin—prostate cancer	4.74e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Mental disorder—Prednisone—prostate cancer	4.74e-05	0.000522	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Estradiol—prostate cancer	4.73e-05	0.000521	CcSEcCtD
Sulfamethoxazole—Leukopenia—Capecitabine—prostate cancer	4.73e-05	0.000521	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—prostate cancer	4.73e-05	0.000521	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Epirubicin—prostate cancer	4.71e-05	0.000519	CcSEcCtD
Sulfamethoxazole—Infestation—Epirubicin—prostate cancer	4.71e-05	0.000519	CcSEcCtD
Sulfamethoxazole—Malnutrition—Prednisone—prostate cancer	4.71e-05	0.000518	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Epirubicin—prostate cancer	4.67e-05	0.000514	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Etoposide—prostate cancer	4.66e-05	0.000513	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—prostate cancer	4.65e-05	0.000512	CcSEcCtD
Sulfamethoxazole—Arthralgia—Docetaxel—prostate cancer	4.65e-05	0.000512	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—prostate cancer	4.65e-05	0.000511	CcSEcCtD
Sulfamethoxazole—Renal failure—Epirubicin—prostate cancer	4.63e-05	0.00051	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—prostate cancer	4.63e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Asthenia—Mitoxantrone—prostate cancer	4.63e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—prostate cancer	4.62e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Epirubicin—prostate cancer	4.62e-05	0.000508	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.62e-05	0.000508	CcSEcCtD
Sulfamethoxazole—Cough—Capecitabine—prostate cancer	4.61e-05	0.000508	CcSEcCtD
Sulfamethoxazole—Stomatitis—Epirubicin—prostate cancer	4.59e-05	0.000506	CcSEcCtD
Sulfamethoxazole—Dizziness—Estradiol—prostate cancer	4.58e-05	0.000503	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—prostate cancer	4.57e-05	0.000503	CcSEcCtD
Sulfamethoxazole—Arthralgia—Capecitabine—prostate cancer	4.5e-05	0.000495	CcSEcCtD
Sulfamethoxazole—Myalgia—Capecitabine—prostate cancer	4.5e-05	0.000495	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.47e-05	0.000492	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—prostate cancer	4.46e-05	0.000491	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—prostate cancer	4.46e-05	0.00049	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—prostate cancer	4.46e-05	0.00049	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Mitoxantrone—prostate cancer	4.41e-05	0.000485	CcSEcCtD
Sulfamethoxazole—Dapsone—CYP3A4—prostate cancer	4.41e-05	0.0265	CrCbGaD
Sulfamethoxazole—Vomiting—Estradiol—prostate cancer	4.4e-05	0.000484	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—prostate cancer	4.4e-05	0.000484	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—prostate cancer	4.39e-05	0.000483	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—prostate cancer	4.39e-05	0.000483	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—prostate cancer	4.37e-05	0.000481	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—prostate cancer	4.36e-05	0.00048	CcSEcCtD
Sulfamethoxazole—Rash—Estradiol—prostate cancer	4.36e-05	0.00048	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—prostate cancer	4.36e-05	0.00048	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—prostate cancer	4.36e-05	0.00048	CcSEcCtD
Sulfamethoxazole—Dermatitis—Estradiol—prostate cancer	4.36e-05	0.00048	CcSEcCtD
Sulfamethoxazole—Headache—Estradiol—prostate cancer	4.33e-05	0.000477	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—prostate cancer	4.33e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	4.32e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—prostate cancer	4.32e-05	0.0259	CrCbGaD
Sulfamethoxazole—Angioedema—Prednisone—prostate cancer	4.3e-05	0.000474	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—prostate cancer	4.29e-05	0.000472	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—prostate cancer	4.27e-05	0.00047	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—prostate cancer	4.26e-05	0.000469	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—prostate cancer	4.25e-05	0.000468	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—prostate cancer	4.25e-05	0.000467	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—prostate cancer	4.24e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—prostate cancer	4.24e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Capecitabine—prostate cancer	4.23e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisone—prostate cancer	4.23e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—prostate cancer	4.23e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Capecitabine—prostate cancer	4.22e-05	0.000465	CcSEcCtD
Sulfamethoxazole—Skin disorder—Capecitabine—prostate cancer	4.19e-05	0.000461	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—prostate cancer	4.18e-05	0.00046	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—prostate cancer	4.16e-05	0.000458	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—prostate cancer	4.15e-05	0.000456	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—prostate cancer	4.12e-05	0.000454	CcSEcCtD
Sulfamethoxazole—Anorexia—Capecitabine—prostate cancer	4.11e-05	0.000453	CcSEcCtD
Sulfamethoxazole—Nausea—Estradiol—prostate cancer	4.11e-05	0.000452	CcSEcCtD
Sulfamethoxazole—Vomiting—Mitoxantrone—prostate cancer	4.1e-05	0.000451	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisone—prostate cancer	4.08e-05	0.000449	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—prostate cancer	4.07e-05	0.000448	CcSEcCtD
Sulfamethoxazole—Rash—Mitoxantrone—prostate cancer	4.07e-05	0.000447	CcSEcCtD
Sulfamethoxazole—Dermatitis—Mitoxantrone—prostate cancer	4.06e-05	0.000447	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.06e-05	0.000447	CcSEcCtD
Sulfamethoxazole—Headache—Mitoxantrone—prostate cancer	4.04e-05	0.000444	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—prostate cancer	4.03e-05	0.000444	CcSEcCtD
Sulfamethoxazole—Myalgia—Prednisone—prostate cancer	4.01e-05	0.000441	CcSEcCtD
Sulfamethoxazole—Arthralgia—Prednisone—prostate cancer	4.01e-05	0.000441	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—prostate cancer	4e-05	0.00044	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.98e-05	0.000438	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—prostate cancer	3.97e-05	0.000437	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—prostate cancer	3.95e-05	0.000435	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Etoposide—prostate cancer	3.95e-05	0.000435	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—prostate cancer	3.95e-05	0.000434	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.93e-05	0.000433	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—prostate cancer	3.92e-05	0.000432	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—prostate cancer	3.92e-05	0.000431	CcSEcCtD
Sulfamethoxazole—Insomnia—Capecitabine—prostate cancer	3.9e-05	0.000429	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—prostate cancer	3.87e-05	0.000426	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—prostate cancer	3.87e-05	0.000425	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—prostate cancer	3.85e-05	0.000423	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—prostate cancer	3.85e-05	0.000423	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—prostate cancer	3.85e-05	0.000423	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Capecitabine—prostate cancer	3.85e-05	0.000423	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisone—prostate cancer	3.84e-05	0.000423	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—prostate cancer	3.84e-05	0.000423	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—prostate cancer	3.84e-05	0.000422	CcSEcCtD
Sulfamethoxazole—Nausea—Mitoxantrone—prostate cancer	3.83e-05	0.000421	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—prostate cancer	3.82e-05	0.000421	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—prostate cancer	3.81e-05	0.00042	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Capecitabine—prostate cancer	3.8e-05	0.000418	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—prostate cancer	3.8e-05	0.000418	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—prostate cancer	3.79e-05	0.000417	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Prednisone—prostate cancer	3.77e-05	0.000415	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Capecitabine—prostate cancer	3.75e-05	0.000413	CcSEcCtD
Sulfamethoxazole—Skin disorder—Prednisone—prostate cancer	3.73e-05	0.000411	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Capecitabine—prostate cancer	3.73e-05	0.00041	CcSEcCtD
Sulfamethoxazole—Fatigue—Capecitabine—prostate cancer	3.72e-05	0.000409	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—prostate cancer	3.71e-05	0.000408	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—prostate cancer	3.7e-05	0.000407	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—prostate cancer	3.68e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—prostate cancer	3.67e-05	0.000404	CcSEcCtD
Sulfamethoxazole—Anorexia—Prednisone—prostate cancer	3.66e-05	0.000403	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—prostate cancer	3.66e-05	0.000403	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—prostate cancer	3.65e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—prostate cancer	3.64e-05	0.000401	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—prostate cancer	3.61e-05	0.000398	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—prostate cancer	3.58e-05	0.000394	CcSEcCtD
Sulfamethoxazole—Dizziness—Etoposide—prostate cancer	3.55e-05	0.00039	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—prostate cancer	3.54e-05	0.000389	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Capecitabine—prostate cancer	3.53e-05	0.000388	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—prostate cancer	3.53e-05	0.000388	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—prostate cancer	3.52e-05	0.000388	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—prostate cancer	3.52e-05	0.000388	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—prostate cancer	3.51e-05	0.000387	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Prednisone—prostate cancer	3.5e-05	0.000385	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisone—prostate cancer	3.48e-05	0.000383	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—prostate cancer	3.43e-05	0.000377	CcSEcCtD
Sulfamethoxazole—Urticaria—Capecitabine—prostate cancer	3.43e-05	0.000377	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Capecitabine—prostate cancer	3.41e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Capecitabine—prostate cancer	3.41e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Vomiting—Etoposide—prostate cancer	3.41e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—prostate cancer	3.41e-05	0.000375	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Prednisone—prostate cancer	3.38e-05	0.000372	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—prostate cancer	3.38e-05	0.000372	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—prostate cancer	3.38e-05	0.000372	CcSEcCtD
Sulfamethoxazole—Headache—Etoposide—prostate cancer	3.36e-05	0.00037	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—prostate cancer	3.34e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Prednisone—prostate cancer	3.34e-05	0.000368	CcSEcCtD
Sulfamethoxazole—Fatigue—Prednisone—prostate cancer	3.31e-05	0.000365	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—prostate cancer	3.31e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—prostate cancer	3.31e-05	0.000364	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—prostate cancer	3.3e-05	0.000363	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—prostate cancer	3.28e-05	0.000361	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—prostate cancer	3.21e-05	0.000354	CcSEcCtD
Sulfamethoxazole—Asthenia—Docetaxel—prostate cancer	3.2e-05	0.000352	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—prostate cancer	3.19e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Nausea—Etoposide—prostate cancer	3.19e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Capecitabine—prostate cancer	3.18e-05	0.00035	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—prostate cancer	3.15e-05	0.000347	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Prednisone—prostate cancer	3.14e-05	0.000346	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—prostate cancer	3.14e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—prostate cancer	3.14e-05	0.000345	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.11e-05	0.000343	CcSEcCtD
Sulfamethoxazole—Asthenia—Capecitabine—prostate cancer	3.1e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—prostate cancer	3.06e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisone—prostate cancer	3.05e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Pruritus—Capecitabine—prostate cancer	3.05e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—prostate cancer	3.05e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—prostate cancer	3.05e-05	0.000336	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Prednisone—prostate cancer	3.04e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Prednisone—prostate cancer	3.04e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—prostate cancer	3.01e-05	0.000331	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—prostate cancer	2.97e-05	0.000327	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—prostate cancer	2.95e-05	0.000325	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Capecitabine—prostate cancer	2.95e-05	0.000325	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—prostate cancer	2.95e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—prostate cancer	2.95e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—prostate cancer	2.94e-05	0.000324	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—prostate cancer	2.92e-05	0.000321	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—prostate cancer	2.9e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—prostate cancer	2.9e-05	0.000319	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.88e-05	0.000317	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—prostate cancer	2.87e-05	0.000315	CcSEcCtD
Sulfamethoxazole—Dizziness—Capecitabine—prostate cancer	2.85e-05	0.000314	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—prostate cancer	2.83e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisone—prostate cancer	2.83e-05	0.000312	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—prostate cancer	2.81e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—prostate cancer	2.81e-05	0.000309	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—prostate cancer	2.79e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—prostate cancer	2.78e-05	0.000306	CcSEcCtD
Sulfamethoxazole—Asthenia—Prednisone—prostate cancer	2.76e-05	0.000303	CcSEcCtD
Sulfamethoxazole—Vomiting—Capecitabine—prostate cancer	2.74e-05	0.000302	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.74e-05	0.000301	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—prostate cancer	2.73e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—prostate cancer	2.72e-05	0.0003	CcSEcCtD
Sulfamethoxazole—Rash—Capecitabine—prostate cancer	2.72e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Pruritus—Prednisone—prostate cancer	2.72e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Insomnia—Epirubicin—prostate cancer	2.72e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Dermatitis—Capecitabine—prostate cancer	2.72e-05	0.000299	CcSEcCtD
Sulfamethoxazole—Headache—Capecitabine—prostate cancer	2.7e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—prostate cancer	2.7e-05	0.000297	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—prostate cancer	2.68e-05	0.000295	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—prostate cancer	2.65e-05	0.000292	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—prostate cancer	2.65e-05	0.000291	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—prostate cancer	2.65e-05	0.000291	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Prednisone—prostate cancer	2.63e-05	0.000289	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Epirubicin—prostate cancer	2.61e-05	0.000288	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—prostate cancer	2.6e-05	0.000286	CcSEcCtD
Sulfamethoxazole—Fatigue—Epirubicin—prostate cancer	2.59e-05	0.000285	CcSEcCtD
Sulfamethoxazole—Nausea—Capecitabine—prostate cancer	2.56e-05	0.000282	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisone—prostate cancer	2.54e-05	0.00028	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.53e-05	0.000279	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—prostate cancer	2.52e-05	0.000277	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—prostate cancer	2.48e-05	0.000273	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—prostate cancer	2.46e-05	0.00027	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—prostate cancer	2.45e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Vomiting—Prednisone—prostate cancer	2.44e-05	0.000269	CcSEcCtD
Sulfamethoxazole—Rash—Prednisone—prostate cancer	2.42e-05	0.000267	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisone—prostate cancer	2.42e-05	0.000266	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—prostate cancer	2.42e-05	0.000266	CcSEcCtD
Sulfamethoxazole—Headache—Prednisone—prostate cancer	2.41e-05	0.000265	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.4e-05	0.000264	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—prostate cancer	2.4e-05	0.000264	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—prostate cancer	2.39e-05	0.000263	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Epirubicin—prostate cancer	2.38e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—prostate cancer	2.38e-05	0.000261	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisone—prostate cancer	2.28e-05	0.000251	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—prostate cancer	2.27e-05	0.00025	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Epirubicin—prostate cancer	2.21e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—prostate cancer	2.21e-05	0.000243	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—prostate cancer	2.2e-05	0.000242	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—prostate cancer	2.2e-05	0.000242	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—prostate cancer	2.16e-05	0.000237	CcSEcCtD
Sulfamethoxazole—Pruritus—Epirubicin—prostate cancer	2.13e-05	0.000234	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Epirubicin—prostate cancer	2.06e-05	0.000226	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—prostate cancer	2.05e-05	0.000225	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—prostate cancer	2e-05	0.00022	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—prostate cancer	1.99e-05	0.000219	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—prostate cancer	1.97e-05	0.000217	CcSEcCtD
Sulfamethoxazole—Vomiting—Epirubicin—prostate cancer	1.91e-05	0.00021	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—prostate cancer	1.9e-05	0.000209	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—prostate cancer	1.9e-05	0.000209	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—prostate cancer	1.89e-05	0.000208	CcSEcCtD
Sulfamethoxazole—Headache—Epirubicin—prostate cancer	1.88e-05	0.000207	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—prostate cancer	1.84e-05	0.000202	CcSEcCtD
Sulfamethoxazole—Nausea—Epirubicin—prostate cancer	1.79e-05	0.000196	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—prostate cancer	1.77e-05	0.000195	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—prostate cancer	1.75e-05	0.000193	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—prostate cancer	1.75e-05	0.000193	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—prostate cancer	1.74e-05	0.000192	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—prostate cancer	1.65e-05	0.000182	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metabolism—PRKACB—prostate cancer	2.34e-06	2.4e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKR1C3—prostate cancer	2.34e-06	2.4e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PRKACB—prostate cancer	2.33e-06	2.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	2.32e-06	2.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP17A1—prostate cancer	2.32e-06	2.38e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.31e-06	2.37e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP17A1—prostate cancer	2.31e-06	2.36e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—JAK2—prostate cancer	2.29e-06	2.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SULT2A1—prostate cancer	2.29e-06	2.35e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1A1—prostate cancer	2.29e-06	2.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.29e-06	2.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.28e-06	2.34e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.27e-06	2.33e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ERCC2—prostate cancer	2.27e-06	2.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MED12—prostate cancer	2.25e-06	2.31e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACSL4—prostate cancer	2.24e-06	2.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.24e-06	2.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GNG5—prostate cancer	2.24e-06	2.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOA2—prostate cancer	2.21e-06	2.26e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—prostate cancer	2.2e-06	2.26e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOA2—prostate cancer	2.2e-06	2.25e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CB—prostate cancer	2.18e-06	2.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA3—prostate cancer	2.15e-06	2.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ARG2—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PHGDH—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UMPS—prostate cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—prostate cancer	2.13e-06	2.19e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.12e-06	2.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A5—prostate cancer	2.11e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LDHB—prostate cancer	2.1e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	2.1e-06	2.16e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A5—prostate cancer	2.1e-06	2.15e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARA—prostate cancer	2.09e-06	2.15e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—INS—prostate cancer	2.08e-06	2.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.06e-06	2.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP2E1—prostate cancer	2.06e-06	2.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HPGDS—prostate cancer	2.06e-06	2.11e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP2E1—prostate cancer	2.05e-06	2.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2C19—prostate cancer	2.04e-06	2.09e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CREBBP—prostate cancer	2.04e-06	2.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NQO1—prostate cancer	2.04e-06	2.09e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NQO1—prostate cancer	2.02e-06	2.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TH—prostate cancer	2.01e-06	2.06e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—prostate cancer	2e-06	2.05e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TH—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA3—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PDHA1—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UCP3—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TCN2—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ACHE—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.99e-06	2.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP3A4—prostate cancer	1.99e-06	2.03e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.98e-06	2.03e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.97e-06	2.02e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP3A4—prostate cancer	1.97e-06	2.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2A6—prostate cancer	1.97e-06	2.02e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAV1—prostate cancer	1.97e-06	2.02e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.96e-06	2.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.96e-06	2.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1B1—prostate cancer	1.95e-06	2e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1B1—prostate cancer	1.94e-06	1.99e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CD—prostate cancer	1.93e-06	1.98e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKR1C3—prostate cancer	1.92e-06	1.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PRKACB—prostate cancer	1.91e-06	1.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.9e-06	1.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.9e-06	1.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GGT1—prostate cancer	1.89e-06	1.94e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP17A1—prostate cancer	1.89e-06	1.93e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.88e-06	1.93e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GGT1—prostate cancer	1.88e-06	1.93e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NCOA1—prostate cancer	1.86e-06	1.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.86e-06	1.91e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NCOA1—prostate cancer	1.85e-06	1.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP19A1—prostate cancer	1.83e-06	1.88e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—prostate cancer	1.83e-06	1.87e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP19A1—prostate cancer	1.82e-06	1.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.82e-06	1.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA4—prostate cancer	1.82e-06	1.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA2—prostate cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EP300—prostate cancer	1.79e-06	1.84e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—prostate cancer	1.79e-06	1.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA2—prostate cancer	1.78e-06	1.82e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—RXRA—prostate cancer	1.77e-06	1.82e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—RXRA—prostate cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCG5—prostate cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SRC—prostate cancer	1.74e-06	1.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.72e-06	1.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.72e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTA1—prostate cancer	1.71e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.71e-06	1.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—COMT—prostate cancer	1.71e-06	1.75e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—INS—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—COMT—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTO1—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NAT2—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—prostate cancer	1.69e-06	1.73e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CB—prostate cancer	1.69e-06	1.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.68e-06	1.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ITPR1—prostate cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—prostate cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CREBBP—prostate cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ITPR1—prostate cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NQO1—prostate cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.64e-06	1.68e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TH—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLCB2—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LRP2—prostate cancer	1.63e-06	1.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.62e-06	1.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.62e-06	1.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.61e-06	1.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—P4HB—prostate cancer	1.59e-06	1.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.59e-06	1.63e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TYMS—prostate cancer	1.58e-06	1.62e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CD—prostate cancer	1.58e-06	1.62e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TYMS—prostate cancer	1.57e-06	1.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—prostate cancer	1.56e-06	1.6e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—prostate cancer	1.56e-06	1.6e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—prostate cancer	1.55e-06	1.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.55e-06	1.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GGT1—prostate cancer	1.54e-06	1.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LPL—prostate cancer	1.53e-06	1.57e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LPL—prostate cancer	1.52e-06	1.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NCOA1—prostate cancer	1.52e-06	1.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.51e-06	1.55e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.49e-06	1.53e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—prostate cancer	1.49e-06	1.53e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MED12—prostate cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.48e-06	1.52e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GNG5—prostate cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A1—prostate cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ERCC2—prostate cancer	1.47e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ERCC2—prostate cancer	1.46e-06	1.5e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—prostate cancer	1.46e-06	1.49e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—prostate cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—RXRA—prostate cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA3—prostate cancer	1.42e-06	1.46e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.4e-06	1.44e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—EP300—prostate cancer	1.39e-06	1.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—COMT—prostate cancer	1.39e-06	1.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—prostate cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—prostate cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CB—prostate cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—prostate cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—prostate cancer	1.36e-06	1.4e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ITPR1—prostate cancer	1.36e-06	1.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HPGDS—prostate cancer	1.36e-06	1.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARA—prostate cancer	1.35e-06	1.39e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.35e-06	1.38e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARA—prostate cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.34e-06	1.37e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—prostate cancer	1.33e-06	1.36e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACHE—prostate cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—prostate cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TYMS—prostate cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—prostate cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAV1—prostate cancer	1.27e-06	1.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—prostate cancer	1.27e-06	1.3e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAV1—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PRKACB—prostate cancer	1.26e-06	1.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LPL—prostate cancer	1.25e-06	1.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.22e-06	1.25e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.21e-06	1.24e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.2e-06	1.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ERCC2—prostate cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—prostate cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA2—prostate cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—prostate cancer	1.15e-06	1.18e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—EP300—prostate cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—prostate cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.1e-06	1.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARA—prostate cancer	1.1e-06	1.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—INS—prostate cancer	1.1e-06	1.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NQO1—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—INS—prostate cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—prostate cancer	1.08e-06	1.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TH—prostate cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CREBBP—prostate cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CREBBP—prostate cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.05e-06	1.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAV1—prostate cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—prostate cancer	1.03e-06	1.05e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GGT1—prostate cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CD—prostate cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NCOA1—prostate cancer	9.99e-07	1.02e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.89e-07	1.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	9.85e-07	1.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—prostate cancer	9.62e-07	9.86e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—prostate cancer	9.56e-07	9.8e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RXRA—prostate cancer	9.5e-07	9.74e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—prostate cancer	9.43e-07	9.67e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—COMT—prostate cancer	9.16e-07	9.39e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—prostate cancer	9.11e-07	9.34e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ITPR1—prostate cancer	8.97e-07	9.19e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—INS—prostate cancer	8.92e-07	9.15e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CB—prostate cancer	8.88e-07	9.1e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CB—prostate cancer	8.83e-07	9.05e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—prostate cancer	8.8e-07	9.02e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—prostate cancer	8.75e-07	8.97e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CREBBP—prostate cancer	8.74e-07	8.96e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TYMS—prostate cancer	8.47e-07	8.68e-06	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—prostate cancer	8.39e-07	8.61e-06	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—prostate cancer	8.38e-07	8.59e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—prostate cancer	8.37e-07	8.58e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CD—prostate cancer	8.29e-07	8.5e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LPL—prostate cancer	8.22e-07	8.43e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	7.94e-07	8.14e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ERCC2—prostate cancer	7.87e-07	8.07e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—prostate cancer	7.83e-07	8.02e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—prostate cancer	7.67e-07	7.86e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—prostate cancer	7.63e-07	7.82e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—prostate cancer	7.4e-07	7.59e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—EP300—prostate cancer	7.31e-07	7.5e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—EP300—prostate cancer	7.27e-07	7.46e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARA—prostate cancer	7.26e-07	7.44e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CB—prostate cancer	7.22e-07	7.41e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—prostate cancer	7.16e-07	7.34e-06	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—prostate cancer	6.84e-07	7.02e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAV1—prostate cancer	6.83e-07	7e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—prostate cancer	6.24e-07	6.4e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.22e-07	6.37e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—EP300—prostate cancer	5.95e-07	6.1e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—INS—prostate cancer	5.89e-07	6.03e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CREBBP—prostate cancer	5.76e-07	5.91e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.47e-07	5.6e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—prostate cancer	5.41e-07	5.55e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—prostate cancer	5.38e-07	5.52e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—prostate cancer	5.16e-07	5.29e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.76e-07	4.88e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—prostate cancer	4.72e-07	4.84e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—prostate cancer	4.42e-07	4.53e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—prostate cancer	4.4e-07	4.51e-06	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—prostate cancer	4.4e-07	4.51e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—prostate cancer	4.12e-07	4.22e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—EP300—prostate cancer	3.93e-07	4.02e-06	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—prostate cancer	3.6e-07	3.69e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.9e-07	2.98e-06	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—prostate cancer	2.37e-07	2.43e-06	CbGpPWpGaD
